Aspirin in hepatocellular carcinoma: is it an out-of-date or promising treatment?

阿司匹林 医学 肝细胞癌 背景(考古学) 癌症 内科学 肝硬化 乙型肝炎 胃肠病学 肿瘤科
作者
Xun Qiu,Fengqiang Gao,Kai Wang,Zhensheng Zhang,Chuxiao Shao,Xiao Xu
出处
期刊:iLIVER
标识
DOI:10.1016/j.iliver.2022.03.003
摘要

Hepatocellular carcinoma (HCC) is one of the most aggressive human malignancies with a dismal survival rate. Few strategies can effectively prevent the occurrence of HCC. Although immunotherapy has significantly improved HCC-related survival in recent years, this systemic therapy is very expensive and lays a heavy burden on most HCC patients. Aspirin, which is currently one of the most widely used medications in analgesic and cardiovascular diseases, is reported to have anti-tumor effects on HCC. Most importantly, long-term administration of low-dose aspirin does not significantly increase the risk of gastrointestinal bleeding. Owing to its cost-effectiveness and wide use, aspirin can be easily applied as an HCC treatment and is affordable for a wide range of patients. Therefore, deeper understanding and more attention are needed to extend the frontline of aspirin's preventive and therapeutic potential into cancer research and management. In this review, we discuss the preventive effect of aspirin on HCC in the context of different etiological factors, including hepatitis B or hepatitis C virus infection, non-alcoholic fatty liver disease, and alcohol-associated liver disease. The therapeutic role of aspirin in resectable or unresectable HCC management is also discussed. Furthermore, the mechanisms underlying the anti-cancer effects of aspirin on HCC are fully reviewed and discussed in the following two aspects: the effect of aspirin on multi-oncogenic signaling pathways in HCC (e.g., AMPK, Wnt/β-catenin, NF-κB) and aspirin-mediated immunometabolic responses in liver diseases. These findings indicate aspirin is a promising agent for populations at risk and HCC patients to prevent or treat HCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
甜甜香旋完成签到,获得积分10
1秒前
小宁同学发布了新的文献求助10
2秒前
xgx984完成签到,获得积分10
2秒前
pearlwh1227发布了新的文献求助20
2秒前
2秒前
zzc发布了新的文献求助10
3秒前
专注大门完成签到,获得积分10
3秒前
桂花酒酿发布了新的文献求助10
4秒前
4秒前
认真路灯完成签到 ,获得积分10
4秒前
俭朴的身影完成签到,获得积分10
4秒前
guishen10发布了新的文献求助10
4秒前
6秒前
今夜有雨完成签到 ,获得积分10
6秒前
7秒前
结草衔环完成签到,获得积分10
7秒前
应应完成签到,获得积分10
7秒前
zzc完成签到,获得积分10
8秒前
NCS完成签到 ,获得积分10
8秒前
sutharsons应助石子采纳,获得30
9秒前
9秒前
黄毅发布了新的文献求助10
10秒前
今后应助张小小采纳,获得30
10秒前
科研通AI2S应助susu采纳,获得10
10秒前
霍冷荷完成签到,获得积分10
10秒前
11秒前
13123发布了新的文献求助10
11秒前
杲杲完成签到 ,获得积分10
11秒前
王梽旭发布了新的文献求助10
11秒前
松松包完成签到,获得积分10
12秒前
苏雨康发布了新的文献求助10
12秒前
爱吃棒棒糖的猫完成签到,获得积分10
13秒前
13秒前
MQhhh完成签到,获得积分10
13秒前
小朱同学完成签到,获得积分20
14秒前
14秒前
guishen10完成签到,获得积分10
14秒前
Xiaoxiao应助susu采纳,获得10
15秒前
wang完成签到 ,获得积分10
16秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Mechanistic Modeling of Gas-Liquid Two-Phase Flow in Pipes 2500
Kelsen’s Legacy: Legal Normativity, International Law and Democracy 1000
Handbook on Inequality and Social Capital 800
Conference Record, IAS Annual Meeting 1977 610
Interest Rate Modeling. Volume 3: Products and Risk Management 600
Interest Rate Modeling. Volume 2: Term Structure Models 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3546764
求助须知:如何正确求助?哪些是违规求助? 3123808
关于积分的说明 9356884
捐赠科研通 2822427
什么是DOI,文献DOI怎么找? 1551441
邀请新用户注册赠送积分活动 723417
科研通“疑难数据库(出版商)”最低求助积分说明 713756